negative impacts of glp 1 The expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions Side Effects: Endocrine Society Journals

High obesity prevalence, expanding cardiovascular indications, recent oral formulation approvals, and intensifying competition between semaglutide and tirzepatide are supporting U.S

As well as helping to lower blood sugar levels, GLP-1 Agonists have important anti-inflammatory effects, can help protect the lungs and have a positive effect on the bacteria in the gut

People with a BMI below 27 need further clinical evaluation to determine if a GLP-1 medication is appropriate for them

No, semaglutide does not increase UTI risk based on FDA prescribing information and clinical trials

Prescription GLP-1 receptor agonists may be indicated for adults with type 2 diabetes not meeting glycemic targets, those with established cardiovascular disease or chronic kidney disease, or individuals with obesity and weight-related complications when lifestyle interventions prove insufficient